Medicare Enrolled

Dr. Iftikhar Chowdhry, M.D.

Rheumatology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3600 GASTON AVE STE 100, Dallas, TX 75246
2148236503
In practice since 2006 (19 years)
NPI: 1154351054 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chowdhry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chowdhry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chowdhry

Dr. Iftikhar Chowdhry is a rheumatology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chowdhry performed 25,894 Medicare services across 7,448 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chowdhry received a total of $231,074 from 65 pharmaceutical and/or device companies across 2012 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chowdhry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 30% volume in TX $231,074 industry payments

Medicare Practice Summary

Medicare Utilization ↗
25,894
Medicare services
Top 30% in TX for rheumatology
7,448
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,363 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 12,000 $18 $23
Joint lubricant injection (Synvisc) 2,593 $7 $10
Office visit, established patient (30-39 min) 1,153 $88 $130
Comprehensive metabolic blood panel 748 $10 $12
Red blood cell sedimentation rate, to detect inflammation, non-automated 732 $4 $5
C-reactive protein test (inflammation marker) 545 $5 $6
Office visit, established patient, complex (40-54 min) 473 $136 $182
Vitamin D level test 433 $29 $30
Thyroid stimulating hormone (TSH) test 433 $16 $18
Ferritin level test (iron stores) 424 $13 $14
Complete blood count (CBC), automated 389 $6 $7
Creatine kinase (cardiac enzyme) level, total 355 $6 $7
Complete blood count (CBC) with differential 340 $8 $9
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 334 $58 $75
Blood draw (venipuncture) 324 $3 $3
Automated urinalysis 321 $2 $3
Iron binding capacity test 320 $8 $9
Folic acid level test 317 $14 $15
Vitamin B-12 level test 315 $15 $15
Iron level test 313 $6 $7
Immunoglobulin level test 199 $9 $11
X-ray of hand, 2 views 190 $24 $33
Injection, methylprednisolone acetate, 80 mg 190 $8 $12
Bone density scan (DEXA) 179 $38 $43
Office visit, established patient (20-29 min) 137 $49 $92
Joint injection, major joint 126 $48 $66
Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk 126 $32 $42
Uric acid level test 113 $4 $5
Urinalysis with microscopic exam 109 $3 $4
Steroid injection (triamcinolone) 109 $1 $1
Administration of chemotherapy into vein, 1 hour or less 98 $104 $139
X-ray of knee, 1-2 views 94 $27 $37
Thyroxine (thyroid chemical), total 93 $7 $8
Thyroid hormone evaluation 93 $6 $8
X-ray of lower and sacral spine, 2-3 views 91 $30 $42
X-ray of foot, 2 views 87 $21 $29
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 86 $51 $69
Administration of chemotherapy into vein, each additional hour 83 $23 $29
Shoulder X-ray, 2+ views 82 $27 $37
X-ray of ankle, 2 views 71 $26 $33
Flu vaccine administration 70 $16 $18
X-ray of middle spine, 2 views 67 $25 $35
X-ray of joint between lower spine and hip bone, 1-2 views 64 $26 $35
Flu vaccine, high-dose 58 $67 $70
Injection of additional new drug or substance into vein 56 $12 $17
Injection, methylprednisolone sodium succinate, up to 40 mg 55 $3 $5
Injection into tendon or ligament 45 $41 $63
New patient office visit, complex (60-74 min) 43 $161 $222
Measurement of complement (immune system proteins), antigen, 41 $11 $14
Measurement of complement function (immune system proteins) 40 $11 $14
X-ray of upper spine, 2-3 views 36 $29 $42
Lipid panel (cholesterol and triglycerides) 36 $12 $29
X-ray of both hips, 2 views 28 $30 $44
X-ray of pelvis, 1-2 views 14 $23 $34
Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free 12 $29 $33
Chest X-ray, 2 views 11 $25 $32
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
61.1% medium
38.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$231,074
Total received (2018-2024)
Avg $33,011/year across 7 years
Top 4% in TX for rheumatology
65
Companies
2,012
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202,635 (87.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,649 (7.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,790 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,179
2023
$32,666
2022
$45,080
2021
$18,969
2020
$13,666
2019
$60,952
2018
$35,562

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$57,295
Amgen Inc.
$32,084
ABBVIE INC.
$31,840
AbbVie Inc.
$28,629
Celgene Corporation
$27,913
Horizon Therapeutics plc
$26,493
Janssen Biotech, Inc.
$5,879
UCB, Inc.
$5,263
Novartis Pharmaceuticals Corporation
$2,580
PFIZER INC.
$2,457
Lilly USA, LLC
$1,064
E.R. Squibb & Sons, L.L.C.
$1,062
GlaxoSmithKline, LLC.
$856
Aurinia Pharma U.S., Inc.
$783
AstraZeneca Pharmaceuticals LP
$732
Mallinckrodt Hospital Products Inc.
$574
ANI Pharmaceuticals, Inc.
$430
VERTEX PHARMACEUTICALS INCORPORATED
$413
Alexion Pharmaceuticals, Inc.
$413
GENZYME CORPORATION
$410
Radius Health, Inc.
$353
Genentech USA, Inc.
$344
ZOLL Medical Corporation
$340
Janssen Scientific Affairs, LLC
$322
Fresenius Kabi USA, LLC
$296
SANOFI-AVENTIS U.S. LLC
$203
Pacira Pharmaceuticals Incorporated
$195
Mallinckrodt LLC
$171
Coloplast Corp
$163
Organon LLC
$132
Mallinckrodt Enterprises LLC
$132
Cardinal Health 110 LLC
$100
Antares Pharma, Inc.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Ferring Pharmaceuticals Inc.
$81
SCILEX PHARMACEUTICALS INC.
$59
Bioventus LLC
$57
Merck Sharp & Dohme Corporation
$55
Organon Llc
$48
DePuy Synthes Sales Inc.
$48
Hikma Pharmaceuticals USA
$47
Pacira Therapeutics, Inc.
$39
MEDAC PHARMA, INC.
$38
TerSera Therapeutics LLC
$38
MEDEXUS PHARMA, INC.
$37
Horizon Pharma plc
$35
GRT US Holding, Inc.
$34
Ultragenyx Pharmaceutical Inc.
$31
Kiniksa Pharmaceuticals International, plc
$29
Celltrion USA Inc.
$28
Exeltis, USA Inc.
$28
Octapharma USA, Inc.
$25
Sobi, Inc
$23
HOSPIRA, INC.
$21
Gilead Sciences, Inc.
$20
Novo Nordisk Inc
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Eisai Inc.
$18
Athena Bioscience, LLC
$16
Kowa Pharmaceuticals America, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Ironwood Pharmaceuticals, Inc
$13
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Alvogen Inc
$12
Mission Pharmacal Company
$11
Top 3 companies account for 52.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BELBUCA · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · Dayvigo · Durolane · EUFLEXXA · EVENITY · Enbrel · Exparel · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LINZESS · LUPKYNIS · LYRICA · Livalo · MONOVISC · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PAXLOVID · PENNSAID · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · QDOLO · QUVIVIQ · Qutenza · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Saxenda · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Titan · Tymlos · ULTOMIRIS · Ultomiris · VPRIV · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for rheumatology in TX.

Equivalent to $892 per 100 Medicare services performed
Looking for a rheumatology specialist in Dallas?
Compare rheumatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
95
Per 100K population
3.6
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chowdhry is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), with speaking/promotional industry engagement in the top 4% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chowdhry experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Chowdhry performed 12,000 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chowdhry receive payments from pharmaceutical companies?
Yes. Dr. Chowdhry received a total of $231,074 from 65 companies across 2,012 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chowdhry's costs compare to other rheumatologists in Dallas?
Dr. Chowdhry's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chowdhry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →